Atul Ltd reported robust growth for the financial year ending March 31, 2026. The company posted a standalone revenue of ₹5,563.57 crore and a profit after tax of ₹595.04 crore. Driven by strong operational performance, the Board of Directors has proposed a dividend of ₹30 per equity share, subject to shareholder approval at the upcoming Annual General Meeting. Additionally, the company announced the reappointment of Mr. Samveg Lalbhai as Managing Director.
Financial Highlights for FY2026
Atul Ltd delivered a strong performance for the fiscal year ended March 31, 2026. On a standalone basis, the company achieved total income of ₹5,762.48 crore, representing significant growth compared to the previous year. The standalone profit for the period climbed to ₹595.04 crore, up from ₹456.28 crore in the previous year. On a consolidated basis, total income reached ₹6,476.44 crore, with a consolidated net profit attributable to the company’s owners of ₹677.90 crore.
Dividend and Shareholder Information
Reflecting its strong financial position, the Board of Directors has recommended a dividend of ₹30 per equity share (300% of the face value of ₹10) for the financial year ended March 31, 2026. The payment of this dividend is subject to the approval of members at the Annual General Meeting (AGM) scheduled for July 31, 2026. The record date for determining the eligibility of members to receive the dividend has been set for July 17, 2026, with the register of members closed from July 18, 2026, to July 24, 2026.
Strategic Leadership Reappointment
In addition to the financial results, the company announced a key leadership continuation. Based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors has reappointed Mr. Samveg Lalbhai as the Managing Director of the company. This reappointment is effective from December 15, 2026, for a further term of five years, subject to necessary approvals.
Operational Performance
The company continues to diversify its operations across key segments. Consolidated segment results for FY2026 highlight the strength of the Life Science Chemicals and Performance and Other Chemicals divisions, which contributed significantly to the overall revenue growth. The company also managed adjustments related to new labour codes, resulting in a net impact on employee benefit expenses, which were effectively accounted for in the final quarterly results.
Source: BSE
